Concepedia

Pulse methotrexate versus pulse actinomycin D in the treatment of low‐risk gestational trophoblastic neoplasia

Fariba Yarandi, Zahra Eftekhar, Hadi Shojaei, Soheyla Kanani, Ali Sharifi, Parviz Hanjani

International Journal of Gynecology & Obstetrics · 2008 · 67 citations · 15 references

DOI

Abstract

Actinomycin D may be a better option than methotrexate as a first-line chemotherapy agent for patients with LR-GTN.

References

15

Risk and prognostic factors in trophoblastic neoplasia

K. D. Bagshawe · Cancer · 1976 · 413 citations · Full text

, , +18

FIGO staging for gestational trophoblastic neoplasia 2000

International Journal of Gynecology & Obstetrics · 2002 · 395 citations

, , +5

EMA/CO for high-risk gestational trophoblastic tumors: results from a cohort of 272 patients.

Mark Bower, E.S. Newlands, L. Holden et al. · Journal of Clinical Oncology · 1997 · 309 citations

Low-Risk Persistent Gestational Trophoblastic Disease: Outcome After Initial Treatment With Low-Dose Methotrexate and Folinic Acid From 1992 to 2000

Iain A. McNeish, Sarah Strickland, L. Holden et al. · Journal of Clinical Oncology · 2002 · 245 citations

Ten years' experience with methotrexate and folinic acid as primary therapy for gestational trophoblastic disease

Ross S. Berkowitz, Donald P. Goldstein, Marilyn R. Bernstein · Gynecologic Oncology · 1986 · 153 citations

, , +8